Şirin Göktuğ, Borlu Fatih
Deparment of Internal Medicine, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
Deparment of Internal Medicine, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Sisli Etfal Hastan Tip Bul. 2019 Jul 10;53(2):172-178. doi: 10.14744/SEMB.2018.45336. eCollection 2019.
Congestive heart failure (CHF) is a heart disease with a growing incidence and prevalence. Creatine kinase-myocardial base (CK-MB) is generally used to determine myocardial damage; however, it is insufficiently sensitive to measure the relatively low level of myocardial damage that typically occurs in heart failure (HF). The use of cardiac troponins, which are far more sensitive and specific, has become common to identify myocardial damage and permits the detection of even minute amounts of damage. The aim of this study was to ascertain whether cardiac troponin I (cTnI) can be used to detect low-level myocardial damage occurring in CHF in real-life conditions.
Fifty patients with CHF symptoms (Group I) and 20 patients who were evaluated as normal (Group II) were included in this prospective study. The Framingham criteria were used to diagnose HF. Group I was divided into 3 subgroups according to the New York Heart Association classification of functional capacity: Class II, Group A; Class III, Group B, and Class IV, Group C. On the first day of admission, CK-MB and cTnI levels were measured and assessed quantitatively. The cTnI level was compared between these 3 subgroups and between Groups I and II. Linear regression analysis was performed to investigate the relationship between ejection fraction (EF) and cTnI.
The mean cTnI value was 0.084±0.07 ng/mL in Group I and 0.018±0.012 ng/mL in Group II (p=0.0001). The mean cTnI value was 0.047±0.016 ng/mL, 0.080±0.048 ng/mL, and 0.175± 0.102 ng/mL in Groups A, B, and C, respectively. The difference between the subgroups of Group I was statistically significant. In addition, it was observed that there was a significant difference in the EF (%) value between Groups I and II and between Groups A, B, and C. Linear regression analysis revealed an inverse relationship between EF and cTnI (r: -0.66) (p=0.0001).
As the severity of HF increased, the cTnI serum level also increased. This increase was inversely related to the EF value. These results are consistent with other studies in the literature, suggesting that the cTnI level may be a useful marker in the diagnosis and evaluation of severity of HF.
充血性心力衰竭(CHF)是一种发病率和患病率不断上升的心脏病。肌酸激酶同工酶(CK-MB)通常用于确定心肌损伤;然而,它对测量心力衰竭(HF)中通常出现的相对较低水平的心肌损伤不够敏感。使用敏感性和特异性更高的心肌肌钙蛋白来识别心肌损伤已很常见,甚至能检测到微量损伤。本研究的目的是确定心肌肌钙蛋白I(cTnI)是否可用于在实际情况下检测CHF中发生的低水平心肌损伤。
本前瞻性研究纳入了50例有CHF症状的患者(I组)和20例被评估为正常的患者(II组)。采用弗明汉标准诊断HF。I组根据纽约心脏协会心功能分级分为3个亚组:II级,A组;III级,B组;IV级,C组。入院第一天,测量并定量评估CK-MB和cTnI水平。比较这3个亚组之间以及I组和II组之间的cTnI水平。进行线性回归分析以研究射血分数(EF)与cTnI之间的关系。
I组的平均cTnI值为0.084±0.07 ng/mL,II组为0.018±0.012 ng/mL(p = 0.0001)。A组、B组和C组的平均cTnI值分别为0.047±0.016 ng/mL、0.080±0.048 ng/mL和0.175±0.102 ng/mL。I组各亚组之间的差异具有统计学意义。此外,观察到I组与II组之间以及A组、B组和C组之间的EF(%)值存在显著差异。线性回归分析显示EF与cTnI呈负相关(r:-0.66)(p = 0.0001)。
随着HF严重程度的增加,cTnI血清水平也升高。这种升高与EF值呈负相关。这些结果与文献中的其他研究一致,表明cTnI水平可能是HF诊断和严重程度评估中的一个有用标志物。